Global Sleeping Pills (Prescription Drugs) Market Research Report 2021
Global Sleeping Pills (Prescription Drugs) Market Research Report 2021
The Sleeping Pills (Prescription Drugs) study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Sleeping Pills (Prescription Drugs) Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Sleeping Pills (Prescription Drugs) Market Overview:
Global Sleeping Pills (Prescription Drugs) Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Sleeping Pills (Prescription Drugs) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Sleeping Pills (Prescription Drugs) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Sleeping Pills (Prescription Drugs) market in 2020.
Global Sleeping Pills (Prescription Drugs) Market Segmentation
By Type, Sleeping Pills (Prescription Drugs) market has been segmented into:
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)
By Application, Sleeping Pills (Prescription Drugs) market has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Sleeping Pills (Prescription Drugs) market are:
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
1. Market Overview of Sleeping Pills (Prescription Drugs)
1.1 Sleeping Pills (Prescription Drugs) Market Overview
1.1.1 Sleeping Pills (Prescription Drugs) Product Scope
1.1.2 Market Status and Outlook
1.2 Sleeping Pills (Prescription Drugs) Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Sleeping Pills (Prescription Drugs) Historic Market Size by Regions (2015-2020)
1.4 Sleeping Pills (Prescription Drugs) Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Sleeping Pills (Prescription Drugs) Sales Market by Type (2015-2026)
2.1 Global Sleeping Pills (Prescription Drugs) Historic Market Size by Type (2015-2020)
2.2 Global Sleeping Pills (Prescription Drugs) Forecasted Market Size by Type (2021-2026)
2.3 Zolpidem
2.4 Eszopiclone (Lunesta)
2.5 Ramelteon (Rozerem)
2.6 Ativan (lorazepam)
2.7 Adapin (doxepin)
3. Covid-19 Impact Sleeping Pills (Prescription Drugs) Sales Market by Application (2015-2026)
3.1 Global Sleeping Pills (Prescription Drugs) Historic Market Size by Application (2015-2020)
3.2 Global Sleeping Pills (Prescription Drugs) Forecasted Market Size by Application (2021-2026)
3.3 Hospital Pharmacy
3.4 Retail Pharmacy
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Sleeping Pills (Prescription Drugs) Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Sleeping Pills (Prescription Drugs) Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Sleeping Pills (Prescription Drugs) Business
5.1 Sanofi
5.1.1 Sanofi Company Profile
5.1.2 Sanofi Sleeping Pills (Prescription Drugs) Product Specification
5.1.3 Sanofi Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Company Profile
5.2.2 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Specification
5.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Takeda Pharmaceutical
5.3.1 Takeda Pharmaceutical Company Profile
5.3.2 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Specification
5.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Apotex
5.4.1 Apotex Company Profile
5.4.2 Apotex Sleeping Pills (Prescription Drugs) Product Specification
5.4.3 Apotex Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Aurobindo Pharma
5.5.1 Aurobindo Pharma Company Profile
5.5.2 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Specification
5.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Actellon Pharmaceuticals
5.6.1 Actellon Pharmaceuticals Company Profile
5.6.2 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Specification
5.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Allegiant Health
5.7.1 Allegiant Health Company Profile
5.7.2 Allegiant Health Sleeping Pills (Prescription Drugs) Product Specification
5.7.3 Allegiant Health Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Cayman Chemical
5.8.1 Cayman Chemical Company Profile
5.8.2 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Specification
5.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Ambitropin
5.9.1 Ambitropin Company Profile
5.9.2 Ambitropin Sleeping Pills (Prescription Drugs) Product Specification
5.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Hayao
5.10.1 Hayao Company Profile
5.10.2 Hayao Sleeping Pills (Prescription Drugs) Product Specification
5.10.3 Hayao Sleeping Pills (Prescription Drugs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
6.2 North America Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
6.3 North America Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
6.4 North America Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
7.2 East Asia Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
7.3 East Asia Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
7.4 East Asia Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
8. Europe
8.1 Europe Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
8.2 Europe Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
8.3 Europe Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
8.4 Europe Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
9.2 South Asia Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
9.3 South Asia Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
9.4 South Asia Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
10.2 Southeast Asia Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
10.3 Southeast Asia Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
10.4 Southeast Asia Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
11.2 Middle East Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
11.3 Middle East Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
11.4 Middle East Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
12. Africa
12.1 Africa Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
12.2 Africa Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
12.3 Africa Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
12.4 Africa Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
13.2 Oceania Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
13.3 Oceania Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
13.4 Oceania Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
14. South America
14.1 South America Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
14.2 South America Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
14.3 South America Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
14.4 South America Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Sleeping Pills (Prescription Drugs) Market Size (2015-2026)
15.2 Rest of the World Sleeping Pills (Prescription Drugs) Key Players in North America (2015-2020)
15.3 Rest of the World Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
15.4 Rest of the World Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
16 Sleeping Pills (Prescription Drugs) Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Sleeping Pills (Prescription Drugs) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|